Thursday November 26 2009 | Biotechnology feed | All feeds
|
|
Gala Biotech
Download detailed PDF Members: Gala Biotech, a business unit of Cardinal Health, was established in 1996 from technology developed at the University of Wisconsin. Located in Middleton, Wisconsin, this rapidly growing company (currently over 40 employees, including 16 PhD’s) has a wide range of capabilities in the fields of molecular biology, vector biology, cell line development, biopharmaceutical manufacturing, protein biochemistry, and quality systems. Gala’s core proprietary technology is GPEx™ (Gene Product Expression), a gene insertion/expression technology that allows rapid creation of stable, high-expressing mammalian cell lines for a wide variety of gene products. "Gala" is Greek for milk, and the company's original mission was to produce pharmaceutical proteins in the milk of transgenic cows. The gene insertion technology that Gala developed to generate transgenic animals became the basis of Gala's Gene Product Expression or GPEx™ technology for production of recombinant proteins in mammalian cell culture.
This page has been viewed 488 times since April 2007, the link to the organisation's website has been followed 71 times Recent Search Terms used to find this page: transgenic cow, technology | gala biotech | gala biotech | gala biotech | Gala Biotech | gala biotech middleton wi president | gala middleton wi | . Search for more companies in Middleton Search for more companies in Wisconsin This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Gala Biotech | ||||||||||||||||||||||||||||||||||||||||
|